Stocks are modestly higher Tuesday afternoon, as Wall Street shakes off a sluggish open amid a new wave of economic data. February job openings fell to 7.57 million -- slightly below expectations -- and the ISM manufacturing index dipped to 49 in March, signaling contraction. Investors are eyeing President Donald Trump’s tariff plan, which takes effect tomorrow. Plus, The Washington Post reported the Trump administration is now considering a sweeping 20% tariff on most U.S. imports.

Continue reading for more on today's market, including: 

• 2 IPOs that should be on your radar.
• Why Jefferies is bearish on these airline stocks.
• Plus, judge rejects JNJ's settlement offer; PRGS' post-earnings pop; and what's hurting this biopharma stock.

Johnson & Johnson (NYSE:JNJ) stock is seeing unusual options activity today, with 22,000 calls and 23,000 puts exchanged -- double times the average intraday volume. New positions are being opened at the leading weekly 4/4 155-strike put. This comes after a judge rejected the healthcare company’s $10 billion settlement offer over talc-related cancer claims. JNJ was last seen lower 4.6% at $158.20, gapping below its 40-day moving average for the first time since January, though it still holds a 9.1% year-to-date gain.

Progress Software Corp (NASDAQ:PRGS) stock is one of the IXIC's best performers today, last seen up 9.8% at $56.55, after the company announced better-than-expected fiscal first-quarter results. Progress shared profits of $1.31 per share, beating estimates by 27 cents, while revenue of $238 million also topped forecasts. Still, PRGS is down 13.1% so far in 2025.

Axsome Therapeutics Inc (NASDAQ:AXSM) is one of the worst performers on the IXIC today, last seen down 5.3% at $110.51. Today's drop comes after its PARADIGM Phase 3 trial of solriamfetol in major depressive disorder failed to meet its primary goal. AXSM still sports a 43.3% year-over-year lead, with its 80-day moving average stepping up to potentially contain its three-day slide.

Calvin Klein parent PVH Corp (NYSE:PVH) is up 15.6% to trade at $74.69 at last glance, after the company reported better-than-expected fourth-quarter earnings and revenue. The retail concern also announced another $500 million share buyback plan this year, after completing one in 2024, and issued an upbeat annual forecast.

Gapping higher from yesterday's two-year lows, PVH is breaking above pressure at the 20-day moving average, which had been guiding it lower since January. Year to date, the equity is still down 28.9%. 

BMO Capital lowered its price target on PVH to $93 from $106 after the event, while TD Cowen lifted its own to $125 from $110. Broader analyst sentiment is split, with seven of 14 firms in question carrying a "buy," and seven a "hold."

A bout of short covering could account for some of today's pop, as short interest makes up 5.6% of the stock's available float. It would take shorts nearly three days to cover, at PVH's average pace of trading. 

In the options pits, PVH has already seen 11 times the average daily options volume. The January 2026 60-strike put is most active, followed by the April 80 call, with new positions being opened at the latter. 

PVH stock has outperformed options traders volatility expectations over the last 12 months, per its Schaeffer's Volatility Scorecard (SVS) of 86 out of 100. 

Shake Shack Inc (NYSE:SHAK) stock is up 2% to trade at $89.89 at last check, after an upgrade at Loop Capital to "buy" from "hold." The analyst in coverage set is price target at $127, implying a 40% upside after highlighting the fast food company's attractive valuation and sales growth. 

Coming into today, the majority of firms leaned bearish on SHAK, with 12 of the 20 in question calling it a "hold" or worse. Shorts are firmly in control, too. Short interest rose 7% over the past month, and makes up 10.7% of Shake Shack stock's available float. An unwinding of this pessimism could bolster the shares even higher.

SHAK is down more than 30% so far this year, but could today mark its first daily gain in three sessions. The equity is once again testing a ceiling at the 20-day moving average, after slipping back below the trendline following a bounce off its lowest level since July.

Over at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 50-day call/put volume ratio of 1.49 ranks in the 82nd percentile of annual readings. This suggests options traders have been much more bullish than usual.

American Airlines Group Inc (NASDAQ:AAL) and Delta Air Lines Inc (NYSE:DAL) stocks are sliding today, after Jefferies downgraded both airline giants to "hold" from "buy" and issued deep price-target cuts. The analyst cited rising macroeconomic uncertainty and softening corporate travel demand, adding that weak March exit rates could weigh on critical summer bookings. Jefferies slashed its price target on DAL to $46 from $85, and on AAL to $12 from $20.

American Airlines stock was last seen 1.7% lower at $10.37 in premarket, on track to extend its 2025 deficit to 39.5%. AAL remains locked in a long-term downtrend, with a late-January bear gap and pressure from its 20-day moving average keeping the equity near its lowest level since August.

Delta Air Lines stock is down 2% to trade at $42.75, looking to add to its 28% year-to-date loss. DAL dropped 28.2% over the last three months and just yesterday hit its lowest level since August, with the 10-day moving average reinforcing short-term resistance.

Both airline stocks could face further headwinds if additional bearish analyst attention rolls in. Heading into today, 12 of 20 brokerages still rated AAL a "buy" or better, while all 21 covering analysts maintained a "strong buy" rating on DAL -- leaving plenty of room for downgrades that could spark more downside pressure.

Tech stocks are selling off today amid President Donald Trump's latest tariff remarks. Intel Corp (NASDAQ:INTC) shares are no exception, last seen down 1.6% to trade at $22.35, adding to an already steep 49.4% year-over-year deficit. There's likely no relief ahead, either, as Intel appeared on Rocky White's lists of worst S&P 500 Index (SPX) stocks to own in April as well as the second quarter.

Worse yet, Intel stock is among the bottom five performers next month. According to White's data, the security finished April lower seven out of 10 times in the last decade, and averaged a steep 5.5% loss. 

Historical second-quarter data paints an even more disappointing picture. Over the last 10 years, INTC finished the quarter higher only three times, and averaged a 7.7% loss. From their current perch, this mean the shares could end April around $21, and the quarter just above $20.

Despite its recent underperformance, options traders still lean bullish. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the security's 50-day call/put volume ratio of 3.00 sits in the 71st percentile of annual readings. An unwinding of this optimism could pressure INTC even lower.

It's worth noting the stock usually outperformed options traders' volatility expectations in the past year. This is per its Schaeffer's Volatility Scorecard (SVS) of 82 out of 100.